CSIR and Ranbaxy among top PCT applicants

CSIR was always part of this list (taken from www.pharmabiz.com). Good to see that Ranbaxy features here too. It will be a while though before we catch up with South Korea which dominates here.

“India stands third in the list of international patent applications filed by developing countries in 2005, and the Council of Scientific and Industrial Research (CSIR) and Ranbaxy Laboratories are among the top ten users of the PCT from developing countries.

The top ten users of the PCT from developing countries are SamsungElectronics (Republic of Korea), LG Electronics (Republic of Korea), Huawei Technologies (China), Council of Scientific and Industrial Research (India), Ranbaxy Laboratories (India), LG Chem (Republic of Korea), Electronics and Telecommunications Research Institute (Republic of Korea), Agency for Science, Technology and Research (Singapore), ZTE Corporation (China) and NHN Corporation (Republic of Korea). According to Ranbaxy sources, the company has filed 57 patent applications in last quarter of 2005, bringing this figure to a total of 185 patent applications filed during 2005.

.The five top users of the international patent system are United States of America, Japan, Germany, France and the United Kingdom. In 2005, over 134,000 PCT applications were filed, representing a 9.4% increase over the previous year. The Republic of Korea is the 6th biggest user of Patent Cooperation Treaty (PCT) and China is the 10th largest PCT user.”

Tags:

1 thought on “CSIR and Ranbaxy among top PCT applicants”

  1. Your blog is worth bookmarketing, and I’m going to let some of my marketing partners know about your useful resource. Discover how 2 top affiliate marketers lay out entire affiliate marketing systems and reveal all their short cuts, proven tactics, success stories, and guarded secrets, so you too can start to earn jumbo-size affiliate checks home based business

Leave a Comment

Discover more from SpicyIP

Subscribe now to keep reading and get access to the full archive.

Continue reading

Scroll to Top